Yvonne Lungershausen, Avance Clinical CEO, and Young-Sang Kim, Director of CHA Global Clinical Trials Center (CHA University Bundang Medical Center), signed the MOU in Seoul, South Korea.
Yvonne Lungershausen, Avance Clinical CEO, and Young-Sang Kim, Director of CHA Global Clinical Trials Center (CHA University Bundang Medical Center), signed the MOU in Seoul, South Korea.